Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort
Ariel Israel, View ORCID ProfileEugene Merzon, Alejandro A. Schäffer, Yotam Shenhar, Ilan Green, Avivit Golan-Cohen, Eytan Ruppin, Eli Magen, Shlomo Vinker
doi: https://doi.org/10.1101/2021.08.03.21261496
Ariel Israel
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
M.D., Ph.D.Eugene Merzon
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
3Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel
M.D.Alejandro A. Schäffer
2Cancer Data Science Laboratory, National Cancer Institute, Bethesda, MD USA
Ph.D.Yotam Shenhar
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
Ph.D.Ilan Green
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
3Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel
M.D.Avivit Golan-Cohen
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
3Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel
M.D.Eytan Ruppin
2Cancer Data Science Laboratory, National Cancer Institute, Bethesda, MD USA
M.D., Ph.DEli Magen
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
4Medicine C Department, Clinical Immunology and Allergy Division, Barzilai University Medical Center, Ben-Gurion University of the Negev, Ashkelon, Israel
M.D., Ph.D.Shlomo Vinker
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
3Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel
M.D., M.H.A.Article usage
Posted August 05, 2021.
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort
Ariel Israel, Eugene Merzon, Alejandro A. Schäffer, Yotam Shenhar, Ilan Green, Avivit Golan-Cohen, Eytan Ruppin, Eli Magen, Shlomo Vinker
medRxiv 2021.08.03.21261496; doi: https://doi.org/10.1101/2021.08.03.21261496
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort
Ariel Israel, Eugene Merzon, Alejandro A. Schäffer, Yotam Shenhar, Ilan Green, Avivit Golan-Cohen, Eytan Ruppin, Eli Magen, Shlomo Vinker
medRxiv 2021.08.03.21261496; doi: https://doi.org/10.1101/2021.08.03.21261496
Subject Area
Subject Areas
- Addiction Medicine (342)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2625)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12175)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4064)
- Geriatric Medicine (385)
- Health Economics (676)
- Health Informatics (2625)
- Health Policy (997)
- Hematology (360)
- HIV/AIDS (845)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (430)
- Neurology (3832)
- Nursing (209)
- Nutrition (570)
- Oncology (2008)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6499)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)